Advertisement
Advertisement

DXCM

DXCM logo

DexCom, Inc.

61.63
USD
Sponsored
+3.81
+6.59%
May 15, 15:59 UTC -4
Closed
exchange

After-Market

61.61

-0.02
-0.03%

DexCom, Inc. Profile

About

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

Info & Links

CEO

Jacob S. Leach

Headquarters

6340 SEQUENCE DRIVE
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.dexcom.com

Auditor

Deloitte & Touche LLP

Share holders

25

Employees

11,000

DexCom, Inc. Statistics

Valuation Measures

Market Capitalization2

23.77B

Enterprise Value

23.90B

Enterprise Value/EBITDA(ttm)

18.49

Price to Earnings Ratio(ttm)

31.43

Price to Sales(ttm)

5.42

Price to Book(mrq)

9.33

Price to Cash(ytd)

23.72

Profitability

Gross Margin(ttm)

59.95%

Operating Margin(ttm)

17.76%

Profit Margin(ttm)

17.60%

Return on Equity(ttm)

32.12%

Return on Invested Capital(ttm)

21.58%

Return on Assets(ttm)

11.86%

Income Statement

Revenue(ttm)

4.82B

Revenue Per Share(ttm)

12.49

Gross Profit(ttm)

2.96B

EBITDA(ttm)3

1.29B

Net Income Available to Common(ttm)

930.40M

Diluted EPS(ttm)

2.10

Share Statistics

Beta (5Y Monthly)

1.55

52-Week Change

-28.06%

S&P 500 52-Week Change

24.34%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

385.87M

Dividend Yield

0.00%

Float4

383.63M

% Held by Insiders

0.32%

% Held by Institutions

97.75%

Balance Sheet

Total Cash(mrq)

2.42B

Total Cash Per Share(mrq)

6.26

Total Debt(mrq)

1.24B

Total Debt/Equity(mrq)

45.19%

Current Ratio(mrq)

1.88%

Quick Ratio(mrq)

1.59%

Book Value Per Share(mrq)

7.14

Cash Flow

Operating Cash Flow Per Share(ytd)

3.55

Free Cash Flow(ytd)

1.08B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement